News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
Mesothelioma Blog
Latest News
- Mesothelioma Patient Featured on ABC’s BostonMed
- Stand Up 2 Cancer Telethon Scheduled for September 10th – Tune In to Join the Cause to Raise Funds for Mesothelioma and Other Cancers
- All Forms of Asbestos Shown to Cause Mesothelioma
- Mesothelin Finding Could Lead to Early Detection of Mesothelioma
- New York Attorney Calls for International Ban on Mesothelioma-Causing Asbestos
- Protein Can be Reliable for Diagnosing Malignant Mesothelioma
- Biomarker Successes Remain Elusive For Mesothelioma and Cancer Researchers
- Avastin May Not be Effective for Breast Cancer, But is Still an Option for Mesothelioma
- Options for Funding Mesothelioma Research
- Golf Outing to Raise Funds for Mesothelioma Research
Monday, March 17, 2008
Source: BBC News
Reseachers from the Harvard Medical School have recently identifed the enzyme, known as pyruvate kinase, that allows cancer cells to consume the large amounts of glucose that are necessary for their growth and continued propagation. Pyruvate kinase comes in two distinct forms, but only one of the forms—the PKM2 form—enables the consumption of glucose at the rate necessary to sustain tumor growth. When reserachers learned how to knock out PKM2 production and force the enzyme into its other form, they discovered they could stop the growth of the cancerous cells. When they tested this therapy in mice, they found that tumorgenesis was significantly inhibited.
Reserachers have known that tumors consume large amounts of glucose since the pioneering work of Otto Warburn, a Nobel Prize-winning chemist, discovered this over seventy years ago, but until this discovery they have not been able to develop therapies based on the knowledge. PET Scans, one of the major imaging modalities used in cancer diagnostics, are used to identify body-wide tumor growth by using radioactive tracers to examine areas of accelarated glucose consumption. PET has been a hugely successful diagnostic technology and is one of the prime examples of how science has previously incorporated the knowledge of glucose consumption into medicine.
With this discovery, doctors are now hopeful that new treatments can be developed that will literally starve the cancer of glucose and, therefore, stop tumor growth altogther. While the researchers note that all the forms of cancer they looked at during their review exhibitd this enzyme, whatever treatments are created with it will almost certainly have to take into consideration the particular metabolic activity of the individual cancers. More research is certainly needed to confirm these findings, but it appears that the discovery of pyruvate kinase represents a real advancement in our knowledge of the bio-chemical processes that underlie cancerous growth.
Labels: cancer, mesothelioma
posted by Belluck & Fox at 10:39 AM
